T1	Participants 28 108	allogeneic marrow transplantation compared with blood stem cell transplantation.
T2	Participants 291 321	recipients of blood stem cells
T3	Participants 357 378	recipients of marrow.
T4	Participants 416 539	115 patients randomly assigned to receive either allogeneic marrow or filgrastim-mobilized blood stem cell transplantation.
